CorTechs Labs Snags Series B

San Diego-based CorTechs Labs, a developer of medical software, said this morning that it has raised a Series B funding round. Size of the funding round was not disclosed, however, a regulatory filing indicates the round was worth $1.2M. CorTechs Labs said the funding was led by Genting Berhad, via its indirect, wholly owned subsidiary, Dragasac Limited. CorTech Labs develops healthcare software which uses MRI scans to help quantify brain atrophy and diagnose brain disorders. The company said the new funding will go towards product development and sales and marketing. CorTechs Labs is led by Guri Stark. More information »